Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diagnostics Industry In Spotlight As Germany Doubles Down To Prevent Second COVID-19 Wave

Executive Summary

Germany’s authorities are back on guard against COVID-19 following renewed regional outbreaks. Diagnostics manufacturers will continue to play a strong part in bringing the pandemic substantially under control, a recent industry association virtual conference heard.     

You may also be interested in...



PHE For The Chop Over UK’s COVID-19 Response Failings

The jury is out on a proposal that Public Health England is to be revamped, refocused and put under new leadership.

Interview: German Diagnostics Industry Questions Wisdom Of Reducing Coronavirus Test Reimbursement

German reimbursement of COVID-19 confirmatory tests has been reduced by one third, a decision that has frustrated both the testing labs and the diagnostics manufacturers who jointly provided the basis of the system that kept the coronavirus to within manageable proportions nationally.

Germany’s COVID-19 Testing Back Up To Near Peak Levels

COVID-19 PCR testing volumes in Germany have almost reached the peak rate seen at the end of March, giving weight to locally held notions that the virus will be around for many months yet.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142332

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel